Search results
Eli Lilly (LLY) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks· 2 days agoFree Report) closed the most recent trading day at $885.99, moving -0.61% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 0.25% ...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance· 2 days agostock afloat. The only other large drugmaker to have generated such phenomenal returns is Novo...
The Zacks Analyst Blog Highlights Berkshire Hathaway, Eli Lilly, PepsiCo, Hovnanian and IDT
Zacks· 5 days agoStocks recently featured in the blog include: Berkshire Hathaway Inc. (BRK.B Quick QuoteBRK.B - Free Report) , Eli Lilly Co. (LLY Quick QuoteLLY - Free Report) and PepsiCo ...
Here's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today
Zacks· 1 day agoNot only can price performance impact your portfolio, but it can help you compare investment results across sectors and industries as well. What if you'd invested in Eli Lilly (LLY& ...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 1 day agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
Zacks· 3 days agoOn Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted 11-0, unanimously recommending the approval of Eli Lilly's (LLY) Alzheimer's disease drug, donanemab.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Zacks· 5 days agoSector ETF report for FHLC